Indoco Remedies receives 7 US FDA observations for Goa facility
|
Our Bureau, Mumbai
Tuesday, September 8, 2026, 13:45 Hrs [IST]
|
|
|
|
Indoco Remedies Limited announced that United States Food and Drug Administration (FDA) had inspected company’s manufacturing facility at Plant II (Sterile) located at Goa facility from 27th August, 2026 to 4th September, 2026.
On conclusion of the inspection, the company received seven (7) observations in Form 483.
The company is addressing the observations comprehensively and will respond to the US FDA within the stipulated timeframe.
|
|
|
|